Translational Therapeutics and Technologies

As Project moves from the research phase into the development, true technology transfer needs to take place. Therapeutic angiogenesis is an experimental area of treatment of ischemia, the condition which associated with decrease in blood supply to certain body organs. Hepatocellular carcinoma (HCC) is a common solid cancer and the third most frequent cause of cancer-related mortality worldwide Molecular targeted therapies are used for treating HCC.

Recent advances of biological drugs have broadened the scope of therapeutic targets for a variety of human diseases. This holds true for dozens of RNA-based therapeutics currently under clinical investigation for diseases ranging from genetic disorders to HIV infection to various cancers. Proteomics has the ability to interrogate a variety of bio specimens for their protein contents and accurately measure the concentrations of these proteins. Deciphering DNA sequences is essential for virtually all branches of biological research.

  • Patient targeted and molecular therapies
  • Therapeutic angiogenesis
  • Chemotherapeutic agents
  • Next gen sequencing and diagnosis
  • Proteomics, metabolomics and genomics
  • RNAi based therapeutics

Related Conference of Translational Therapeutics and Technologies

Translational Therapeutics and Technologies Conference Speakers